Watch Point Trust Co Has $3.10 Million Holdings in CVS Health Corp (NYSE:CVS)

Watch Point Trust Co lifted its stake in CVS Health Corp (NYSE:CVS) by 26.6% in the second quarter, HoldingsChannel reports. The institutional investor owned 56,872 shares of the pharmacy operator’s stock after buying an additional 11,945 shares during the quarter. Watch Point Trust Co’s holdings in CVS Health were worth $3,099,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Nordea Investment Management AB grew its position in CVS Health by 2.8% during the 1st quarter. Nordea Investment Management AB now owns 12,426,745 shares of the pharmacy operator’s stock worth $670,172,000 after acquiring an additional 340,315 shares during the last quarter. Pinnacle Bank bought a new stake in CVS Health during the 4th quarter worth approximately $157,000. Contravisory Investment Management Inc. bought a new stake in CVS Health during the 1st quarter worth approximately $3,040,000. Owl Creek Asset Management L.P. grew its position in CVS Health by 126.1% during the 4th quarter. Owl Creek Asset Management L.P. now owns 1,750,594 shares of the pharmacy operator’s stock worth $114,699,000 after acquiring an additional 976,494 shares during the last quarter. Finally, M&R Capital Management Inc. grew its position in CVS Health by 3.0% during the 1st quarter. M&R Capital Management Inc. now owns 130,126 shares of the pharmacy operator’s stock worth $6,965,000 after acquiring an additional 3,794 shares during the last quarter. 77.18% of the stock is owned by institutional investors and hedge funds.

CVS traded down $0.35 during mid-day trading on Thursday, reaching $58.21. The stock had a trading volume of 4,480,852 shares, compared to its average volume of 8,160,261. The company has a market cap of $76.38 billion, a PE ratio of 8.22, a P/E/G ratio of 1.29 and a beta of 0.90. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. The stock has a fifty day moving average price of $56.23. CVS Health Corp has a 52 week low of $51.72 and a 52 week high of $82.15.



CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the Zacks’ consensus estimate of $1.70 by $0.19. The firm had revenue of $63.43 billion for the quarter, compared to analyst estimates of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The business’s quarterly revenue was up 35.2% compared to the same quarter last year. During the same period last year, the company earned $1.69 EPS. On average, equities analysts expect that CVS Health Corp will post 6.96 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Stockholders of record on Thursday, July 25th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.44%. The ex-dividend date of this dividend was Wednesday, July 24th. CVS Health’s dividend payout ratio (DPR) is currently 28.25%.

A number of equities research analysts recently commented on the company. Evercore ISI set a $63.00 price target on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, August 7th. ValuEngine lowered CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 2nd. Standpoint Research upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. Guggenheim assumed coverage on CVS Health in a research report on Thursday, April 18th. They set a “buy” rating and a $75.00 price target on the stock. Finally, Raymond James decreased their price target on CVS Health from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a research report on Thursday, April 18th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $75.14.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Story: Stock Symbol

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.